SCHEMBL1723853

SCHEMBL1723853

O=C(N[C@@H](Cc1ccccc1)C(=O)Nc1ccc([N+](=O)[O-])cc1)[C@@H]1CCCN1

nearest known ligand 0.53

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
▸ CTSC P53634 2/20 0.53
▸ USP30 Q70CQ3 4/20 0.50
▸ MEN1 O00255 1/20 0.49
▸ KMT2A Q03164 1/20 0.49
▸ FKBP4 Q02790 1/20 0.48
▸ KLKB1 P03952 2/20 0.46
▸ PRSS1 P07477 1/20 0.46
▸ PRSS2 P07478 1/20 0.46
▸ PRSS3 P35030 1/20 0.46
▸ SSTR3 P32745 1/20 0.46
▸ PLG P00747 1/20 0.46
▸ PLAU P00749 1/20 0.46
▸ FPR1 P21462 2/20 0.46
▸ FPR2 P25090 2/20 0.46
▸ SMN1; SMN2 Q16637 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL29422207 0.87 SSTR3 (0.49) SSTR3
SCHEMBL9013073 0.87 SSTR3 (0.49) CTSCUSP30MEN1KMT2AFKBP4
SCHEMBL7047405 0.87 SSTR3 (0.49) CTSCUSP30MEN1KMT2AFKBP4
Hydrochloric Acid SCHEMBL3277643 0.86 SSTR3 (0.48) CTSCUSP30MEN1KMT2AFKBP4
SCHEMBL7115295 0.85 HDAC3 (0.44) CTSCMEN1KMT2AFKBP4
SCHEMBL1088243 0.84 NAMPT (0.44) MEN1KMT2ASMN1; SMN2
Bromide SCHEMBL11306636 0.83 CTSC (0.51) CTSCMEN1KMT2A
Bromide SCHEMBL11306409 0.83 CTSC (0.51) CTSCMEN1KMT2A
Dl-Phenylalanine SCHEMBL29006902 0.83 CTSC (0.48) CTSCMEN1KMT2ASMN1; SMN2
Bromide SCHEMBL11306412 0.82 CTSC (0.50) CTSCMEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 43 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4518888-A1 IMMUNOBIOTICS FOR PREVENTING BACTERIAL PNEUMONIA AND METHODS OF USING THE SAME The Regents of the University of Colorado, a body corporate (US) 2025-03-12 — — EP disclosed
US-20240317820-A1 IMPROVED BACILLUS PRODUCTION HOST BASF SE (DE) 2024-09-26 — — US disclosed
WO-2023215911-A1 IMMUNOBIOTICS FOR PREVENTING BACTERIAL PNEUMONIA AND METHODS OF USING THE SAME THE REGENTS OF THE UNIVERSITY OF COLORADO, A BODY CORPORATE (US) 2023-11-09 — — WO disclosed
US-20230272358-A1 ALANINE RACEMASE SINGLE DELETION AND TRANSCOMPLEMENTATION BASF SE (DE) 2023-08-31 — — US disclosed
US-20220186234-A1 Industrial Fermentation Process for Bacillus Using Defined Medium and Trace Element Feed BASF SE (DE) 2022-06-16 — — US disclosed
EP-4009809-A1 A METHOD FOR IMPROVING THE NUTRITIONAL VALUE OF ANIMAL FEED DSM IP Assets B.V. (NL) 2022-06-15 — — EP disclosed
EP-3655012-A1 CYCLOSPORIN ANALOGUES AND USES THEREOF Cypralis Limited (GB) 2020-05-27 — — EP disclosed
WO-2019016572-A1 CYCLOSPORIN ANALOGUES AND USES THEREOF CYPRALIS LTD (GB) 2019-01-24 — — WO disclosed
CN-106636043-A Preparation method of protease 广州立白企业集团有限公司 2017-05-10 — — CN disclosed
EP-3003267-A1 NOVEL ORAL PHARMACEUTICAL COMPOSITION FOR TREATMENT OF DIABETES Novo Nordisk A/S (DK) 2016-04-13 — — EP disclosed
EP-0769006-A1 SMALL MOLECULE INHIBITORS OF ROTAMASE ENZYME ACTIVITY GUILFORD PHARMACEUTICALS INC. (US) 1997-04-23 — — EP disclosed
WO-1996040633-A1 SMALL MOLECULE INHIBITORS OF ROTAMASE ENZYME ACTIVITY GUILFORD PHARMACEUTICALS INC. (US) 1996-12-19 — — WO disclosed
EP-0723579-A1 PROTEASE-CONTAINING CLEANING COMPOSITIONS THE PROCTER & GAMBLE COMPANY (US) 1996-07-31 — — EP disclosed
WO-1995010591-A1 PROTEASE-CONTAINING CLEANING COMPOSITIONS THE PROCTER & GAMBLE COMPANY (US) 1995-04-20 — — WO disclosed
EP-0579710-A1 NOVEL PROTEASES FROM DENDRYPHIELLA NOVO NORDISK A/S (DK) 1994-01-26 — — EP disclosed
WO-1993015175-A1 DETERGENT COMPOSITIONS INHIBITING DYE TRANSFER CONTAINING A CATALYST, OXIDATION SCAVENGER AND PEROXIDE GENERATING ENZYME THE PROCTER & GAMBLE COMPANY (US) 1993-08-05 — — WO disclosed
EP-0546156-A4 ISOLATION AND CHARACTERIZATION OF A NOVEL PROTEASE FROM STREPTOMYCES LIVIDANS — 1993-06-30 — — EP disclosed
EP-0546156-A1 ISOLATION AND CHARACTERIZATION OF A NOVEL PROTEASE FROM STREPTOMYCES LIVIDANS AMGEN INC. (US) 1993-06-16 — — EP disclosed
WO-1993000925-A1 ISOLATION AND CHARACTERIZATION OF A NOVEL PROTEASE FROM STREPTOMYCES LIVIDANS AMGEN INC. (US) 1993-01-21 — — WO disclosed
WO-1992018622-A1 NOVEL PROTEASES NOVO NORDISK A/S (DK) 1992-10-29 — — WO disclosed
Send feedback